T. Rowe Price Investment Management
ACHC icon

T. Rowe Price Investment Management’s Acadia Healthcare ACHC Stock Holding History

T. Rowe Price Investment Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-949,569
Closed -$28.8M – 686
2025
Q1 		$28.8M Sell
949,569
-5,166,423
-84% -$197M 0.02% 476
2024
Q4 		$243M Sell
6,115,992
-5,903
-0.1% -$266K 0.15% 152
2024
Q3 		$388M Sell
6,121,895
-1,876,909
-23% -$136M 0.23% 112
2024
Q2 		$540M Sell
7,998,804
-525,470
-6% -$36.7M 0.34% 81
2024
Q1 		$675M Sell
8,524,274
-34,845
-0.4% -$2.85M 0.41% 71
2023
Q4 		$666M Buy
8,559,119
+451,050
+6% +$33.4M 0.43% 73
2023
Q3 		$570M Sell
8,108,069
-7,839
-0.1% -$586K 0.4% 77
2023
Q2 		$646M Buy
8,115,908
+833,620
+11% +$60.2M 0.44% 64
2023
Q1 		$526M Sell
7,282,288
-797,048
-10% -$62.1M 0.38% 77
2022
Q4 		$665M Sell
8,079,336
-1,652,522
-17% -$136M 0.51% 52
2022
Q3 		$761M Buy
+9,731,858
New +$778M 0.61% 41

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

T. Rowe Price Investment Management's ACHC Position: Q2 2025 in Review

T. Rowe Price Investment Management sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 949,569 shares — an estimated $28.8M sold.

T. Rowe Price Investment Management first reported a position in ACHC in Q3 2022 and held it in 11 quarters. The position peaked at $761M in Q3 2022. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

  • T. Rowe Price Investment Management reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 949,569 Acadia Healthcare shares in Q2 2025, an estimated $28.8M.
  • T. Rowe Price Investment Management first reported a position in Acadia Healthcare in Q3 2022 and held it in 11 quarters.
  • T. Rowe Price Investment Management's Acadia Healthcare position peaked at $761M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.